Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2024 Filed Jun 5, 2024 13:33 UTC |
Concannon BrianDirector
|
GrantOptions To Purchase Common Stock · Derivative | 5,503 | $0.00 Strike: $77.18 | $0.00 |
DisclosureSEC source: 0001127602-24-017863 · form4.xml · derivative · entry 3 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,503 Underlying: Common Stock · 5,503 shares Expires 2034-06-03 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:17 UTC |
Lande Jerome J.Director
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017854 · form4.xml · derivative · entry 3 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 302 shares Expires 2033-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:17 UTC |
Lande Jerome J.Director
|
Exercise / conversionCommon Stock | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017854 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:12 UTC |
Workman John LDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017851 · form4.xml · derivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 302 shares Expires 2033-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:12 UTC |
Workman John LDirector
|
Exercise / conversionCommon Stock | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017851 · form4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:11 UTC |
Bronson David M.Director
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017850 · form4.xml · derivative · entry 2 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 302 shares Expires 2033-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:11 UTC |
Bronson David M.Director
|
Exercise / conversionCommon Stock | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017850 · form4.xml · nonDerivative · entry 1 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:08 UTC |
Aronson Martha GoldbergDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017848 · form4.xml · derivative · entry 3 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 302 shares Expires 2033-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:08 UTC |
Aronson Martha GoldbergDirector
|
Exercise / conversionCommon Stock | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017848 · form4.xml · nonDerivative · entry 1 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:09 UTC |
Farkas CharlesDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017849 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 302 shares Expires 2033-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:09 UTC |
Farkas CharlesDirector
|
Exercise / conversionCommon Stock | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017849 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:06 UTC |
Council LaVerne HDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017847 · form4.xml · derivative · entry 2 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 302 shares Expires 2033-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:06 UTC |
Council LaVerne HDirector
|
Exercise / conversionCommon Stock | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017847 · form4.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:05 UTC |
Schwarzentraub Barbara JDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017846 · form4.xml · derivative · entry 3 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 302 shares Expires 2033-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:05 UTC |
Schwarzentraub Barbara JDirector
|
Exercise / conversionCommon Stock | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017846 · form4.xml · nonDerivative · entry 1 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 13:33 UTC |
Concannon BrianDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017863 · form4.xml · derivative · entry 2 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 302 shares Expires 2033-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 13:33 UTC |
Concannon BrianDirector
|
Exercise / conversionCommon Stock | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017863 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2024 Filed May 14, 2024 19:37 UTC |
Bronson David M.Director
|
PurchaseCommon Stock | 1,350 | $72.09 | $97,321.50 |
DisclosureSEC source: 0001127602-24-015246 · form4.xml · nonDerivative · entry 1 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,460 Read SEC document |
| May 08, 2024 Filed May 10, 2024 21:29 UTC |
Schwarzentraub Barbara JDirector
|
PurchaseCommon Stock | 1,442 | $69.26 | $99,872.92 |
DisclosureSEC source: 0001127602-24-015030 · form4.xml · nonDerivative · entry 1 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by The Barbara J. Schwarzentraub Trust Disclosed balance after: 1,442 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $69.13 to $69.45. Full information regarding the number of shares purchased at each separate price will be provided upon request of the Commission staff, or a CONMED security holder. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:20 UTC |
Aronson Martha GoldbergDirector
|
PurchaseCommon Stock | 2,000 | $70.98 | $141,960.00 |
DisclosureSEC source: 0001127602-24-014593 · form4.xml · nonDerivative · entry 1 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by IRA Disclosed balance after: 2,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $70.92 to $71.19. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| April 30, 2024 Filed May 2, 2024 17:03 UTC |
Beyer PatChief Operating Officer
|
PurchaseCommon Stock | 3,000 | $68.30 | $204,900.00 |
DisclosureSEC source: 0001127602-24-013824 · form4.xml · nonDerivative · entry 1 Beyer Pat · CIK 0001627985 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,807 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from 68.29 to 68.40. Full information regarding the number of shares purchased at each separate price will be provided upon request of the commission staff, CONMED or CONMED security holder Read SEC document |
| April 24, 2024 Filed Apr 26, 2024 19:41 UTC |
Beyer PatChief Operating Officer
|
GrantOptions To Purchase Common Stock · Derivative | 20,060 | $70.01 Strike: $70.01 | $1,404,400.60 |
DisclosureSEC source: 0001127602-24-013436 · form4.xml · derivative · entry 1 Beyer Pat · CIK 0001627985 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,060 Underlying: Common Stock · 20,060 shares Expires 2034-04-24 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 28, 2024 Filed Apr 3, 2024 17:51 UTC |
Garner Todd WExecutive Vice President & CFO
|
GrantCommon Stock | 227 | $76.08 | $17,270.16 |
DisclosureSEC source: 0001127602-24-012125 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227 Read SEC document |
| March 28, 2024 Filed Apr 3, 2024 17:47 UTC |
Cohen Heather LEVP & Chief HR & Legal Officer
|
GrantCommon Stock | 227 | $76.08 | $17,270.16 |
DisclosureSEC source: 0001127602-24-012121 · form4.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP & Chief HR & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,992 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:42 UTC |
Cohen Heather LEVP & Chief HR & Legal Officer
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 25,000 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-24-009395 · form4.xml · derivative · entry 6 Cohen Heather L · CIK 0001436649 · EVP & Chief HR & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:42 UTC |
Cohen Heather LEVP & Chief HR & Legal Officer
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 27,500 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-24-009395 · form4.xml · derivative · entry 5 Cohen Heather L · CIK 0001436649 · EVP & Chief HR & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,500 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:42 UTC |
Cohen Heather LEVP & Chief HR & Legal Officer
|
Tax withholdingCommon Stock | 23,847 | $85.23 | $2,032,360.58 |
DisclosureSEC source: 0001127602-24-009395 · form4.xml · nonDerivative · entry 4 Cohen Heather L · CIK 0001436649 · EVP & Chief HR & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,765 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:42 UTC |
Cohen Heather LEVP & Chief HR & Legal Officer
|
Exercise / conversionCommon Stock | 25,000 | $78.76 | $1,969,000.00 |
DisclosureSEC source: 0001127602-24-009395 · form4.xml · nonDerivative · entry 3 Cohen Heather L · CIK 0001436649 · EVP & Chief HR & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:42 UTC |
Cohen Heather LEVP & Chief HR & Legal Officer
|
Tax withholdingCommon Stock | 22,258 | $85.43 | $1,901,389.65 |
DisclosureSEC source: 0001127602-24-009395 · form4.xml · nonDerivative · entry 2 Cohen Heather L · CIK 0001436649 · EVP & Chief HR & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,612 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:42 UTC |
Cohen Heather LEVP & Chief HR & Legal Officer
|
Exercise / conversionCommon Stock | 27,500 | $59.96 | $1,648,900.00 |
DisclosureSEC source: 0001127602-24-009395 · form4.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP & Chief HR & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 15:44 UTC |
Lalomia BrentVice President QA and RA
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 75 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009313 · form4.xml · derivative · entry 3 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150 Underlying: Common Stock · 75 shares Expires 2032-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 15:44 UTC |
Lalomia BrentVice President QA and RA
|
Tax withholdingCommon Stock | 26 | $85.00 | $2,210.00 |
DisclosureSEC source: 0001127602-24-009313 · form4.xml · nonDerivative · entry 2 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 957.057 Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 15:44 UTC |
Lalomia BrentVice President QA and RA
|
Exercise / conversionCommon Stock | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009313 · form4.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 983.057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:39 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
GrantOptions To Purchase Common Stock · Derivative | 18,988 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008540 · form4.xml · derivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,988 Underlying: Common Stock · 18,988 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:33 UTC |
Peters Stanley W IIIPresident AS and AET
|
GrantOptions To Purchase Common Stock · Derivative | 33,508 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008535 · form4.xml · derivative · entry 1 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,508 Underlying: Common Stock · 33,508 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:30 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
GrantOptions To Purchase Common Stock · Derivative | 8,000 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008532 · form4.xml · derivative · entry 1 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:20 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
GrantOptions To Purchase Common Stock · Derivative | 79,154 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008521 · form4.xml · derivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,154 Underlying: Common Stock · 79,154 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:24 UTC |
Lalomia BrentVice President QA and RA
|
GrantOptions To Purchase Common Stock · Derivative | 18,988 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008529 · form4.xml · derivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,988 Underlying: Common Stock · 18,988 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:16 UTC |
Garner Todd WExecutive Vice President & CFO
|
GrantOptions To Purchase Common Stock · Derivative | 44,677 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008515 · form4.xml · derivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,677 Underlying: Common Stock · 44,677 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:13 UTC |
Ferrell John D.Executive Vice President - HR
|
GrantOptions To Purchase Common Stock · Derivative | 11,250 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008512 · form4.xml · derivative · entry 1 Ferrell John D. · CIK 0001980620 · Executive Vice President - HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:10 UTC |
Cohen Heather LEVP & Chief HR & Legal Officer
|
GrantOptions To Purchase Common Stock · Derivative | 33,508 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008507 · form4.xml · derivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP & Chief HR & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,508 Underlying: Common Stock · 33,508 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:01 UTC |
Beyer PatPresident Int'l & Global Ortho
|
GrantOptions To Purchase Common Stock · Derivative | 44,677 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008492 · form4.xml · derivative · entry 1 Beyer Pat · CIK 0001627985 · President Int'l & Global Ortho 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,677 Underlying: Common Stock · 44,677 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:07 UTC |
Clifford Edward A.VP Global Manufacturing
|
GrantOptions To Purchase Common Stock · Derivative | 18,988 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008506 · form4.xml · derivative · entry 1 Clifford Edward A. · CIK 0001988929 · VP Global Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,988 Underlying: Common Stock · 18,988 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 20:56 UTC |
Berge Terence MVP-Corporate Controller
|
GrantOptions To Purchase Common Stock · Derivative | 8,000 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008488 · form4.xml · derivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| December 31, 2023 Filed Feb 5, 2024 23:28 UTC |
Lalomia BrentVice President QA and RA
|
Other401 (K) Plan | 18.243 | $109.51 | $1,997.79 |
DisclosureSEC source: 0001127602-24-003433 · form5.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Indirect · 401 (K) Plan Disclosed balance after: 70.613 F1 · date: As of 12/31/23. Read SEC document |
| December 31, 2023 Filed Feb 5, 2024 23:08 UTC |
Cohen Heather LEVP & Chief HR & Legal Officer
|
Other401 (K) Plan | 37.964 | $109.51 | $4,157.44 |
DisclosureSEC source: 0001127602-24-003426 · form5.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP & Chief HR & Legal Officer 10b5-1 filing: No plan indicated Ownership: Indirect · 401 (K) Plan Disclosed balance after: 5,009.13 F1 · date: As of December 31, 2023. Read SEC document |
| December 31, 2023 Filed Feb 7, 2024 02:40 UTC |
Peters Stanley W IIIPresident AS and AET
|
Other401 (K) Plan | 111.163 | $109.51 | $12,173.46 |
DisclosureSEC source: 0001127602-24-003607 · form5.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Indirect · 401 (K) Plan Disclosed balance after: 1,424.357 F1 · date: As of 12/31/23. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 17:12 UTC |
Peters Stanley W IIIPresident AS and AET
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,300 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-23-028980 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 2,300 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 17:12 UTC |
Peters Stanley W IIIPresident AS and AET
|
SaleCommon Stock | 2,300 | $109.93 | $252,833.48 |
DisclosureSEC source: 0001127602-23-028980 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.91 to $109.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 17:12 UTC |
Peters Stanley W IIIPresident AS and AET
|
Exercise / conversionCommon Stock | 2,300 | $41.93 | $96,439.00 |
DisclosureSEC source: 0001127602-23-028980 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.